INS and diabetes mellitus: Overall, oral insulin did not prevent diabetes in all subjects recruited for that arm of the trial; however, a subsequent analysis indicated a delay in diabetes onset in the subgroup of individuals who had high titres of anti-insulin autoantibodies.